Non-B hepatitis in Japanese recipients of blood transfusions: clinical and serologic studies after the introduction of laboratory screening of donor blood for hepatitis B surface antigen
- PMID: 438550
- DOI: 10.1093/infdis/139.5.511
Non-B hepatitis in Japanese recipients of blood transfusions: clinical and serologic studies after the introduction of laboratory screening of donor blood for hepatitis B surface antigen
Abstract
Cases of hepatitis virus infection in Japanese recipients of blood transfusions were serologically and clinically analyzed after the introduction of laboratory screening of donor blood for hepatitis B surface antigen by counter immunoelectrophoresis. Non-A, non-B hepatitis occurred in 116 (10.7%) and hepatitis type B in nine (0.9%) of the 1,082 recipients. The incubation period of the post-transfusion non-A, non-B hepatitis cases varied from two to 33 weeks, but most occurred within 15 weeks. In 97 (83.6%) of the 116 cases of non-A, non-B hepatitis studied, the duration of abnormal elevation of the level of serum alanine aminotransferase (glutamic-pyruvic transaminase [SGPT]) was 16 weeks. The cases of non-A, non-B hepatitis could be divided into three groups according to the pattern of elevation of SGPT levels. These findings may suggest either a multiple etiology for non-A, non-B hepatitis or a variety of clinical symptoms with a single etiology for the infection.
Similar articles
-
Hepatitis B virus antibody in blood donors and the occurrence of non-A, non-B hepatitis in transfusion recipients. An analysis of the Transfusion-Transmitted Viruses Study.Ann Intern Med. 1984 Dec;101(6):733-8. doi: 10.7326/0003-4819-101-6-733. Ann Intern Med. 1984. PMID: 6437308
-
Donor transaminase and recipient hepatitis. Impact on blood transfusion services.JAMA. 1981 Aug 7;246(6):630-4. JAMA. 1981. PMID: 6788964
-
Post-transfusion hepatitis: current perspectives.Ann Intern Med. 1980 Apr;92(4):539-46. doi: 10.7326/0003-4819-92-4-539. Ann Intern Med. 1980. PMID: 6987932 Review.
-
Serum alanine aminotransferase of donors in relation to the risk of non-A,non-B hepatitis in recipients: the transfusion-transmitted viruses study.N Engl J Med. 1981 Apr 23;304(17):989-94. doi: 10.1056/NEJM198104233041701. N Engl J Med. 1981. PMID: 6782484
-
Posttransfusion hepatitis: clinical features, risk and donor testing.Prog Clin Biol Res. 1985;182:47-61. Prog Clin Biol Res. 1985. PMID: 3929262 Review. No abstract available.
Cited by
-
Effect of concurrent acute infection with hepatitis C virus on acute hepatitis B virus infection.BMJ. 1993 Oct 30;307(6912):1095-7. doi: 10.1136/bmj.307.6912.1095. BMJ. 1993. PMID: 8251805 Free PMC article.
-
Incidence of hepatitis non-A, non-B compared with types A and B in hospital patients.Can Med Assoc J. 1982 Sep 1;127(5):384-6. Can Med Assoc J. 1982. PMID: 6809306 Free PMC article.
-
Post-transfusion hepatitis after cardiac surgery.Br Med J (Clin Res Ed). 1984 Feb 4;288(6414):403-4. doi: 10.1136/bmj.288.6414.403-c. Br Med J (Clin Res Ed). 1984. PMID: 6419942 Free PMC article. No abstract available.
-
[Hepatitis non-A, non-B: epidemiologic, clinical, serologic and morphologic aspects].Klin Wochenschr. 1985 May 2;63(9):389-404. doi: 10.1007/BF01733664. Klin Wochenschr. 1985. PMID: 2582179 German.
-
Hepatitis C virus infection is associated with the development of hepatocellular carcinoma.Proc Natl Acad Sci U S A. 1990 Sep;87(17):6547-9. doi: 10.1073/pnas.87.17.6547. Proc Natl Acad Sci U S A. 1990. PMID: 2168552 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources